Respiri (ASX:RSH) completed the acquisition of the business and assets of Texas-based healthcare service provider Orb Health, according to a Tuesday Australian bourse filing.
It said the initial purchase price of $9 million was satisfied via the issuance of about 161 million ordinary shares.
Orb Health also agreed to invest $700,000 by subscribing for additional shares as part of the deal. Respiri will issue the first tranche of 7.2 million additional shares contemporaneously with the initial consideration shares.
The second tranche of 5.4 million additional shares is expected to be completed within the next 45 days, the filing added.
Orb Health will also be entitled an additional payment via the issuance of ordinary shares, if it meets certain financial targets in 2025.
Respiri's executive chairman Nicholas Smedley will transition to the role of nonexecutive chairman, as part of its restructuring, the filing said.
Its shares rose almost 3% in recent trading on Tuesday.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。